| L-DOPA, | L-dopa levodopa, levo-3, 4-dihydroxyphenylalanine |
|---|
| L-DOPA | L-Dihydroxphenylalanine |
|---|---|
| L-DOPA | L-beta-(3,4-dihydroxyphenyl)alanine |
| L-DOPA | Levodopa |
| l-dopa | <chemical> The naturally occurring form of dopa and the immediate precursor of dopamine. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to dopamine. It is used for the treatment of parkinsonism and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. Pharmacological action: antiparkinson agents, dopamine agents. (12 Dec 1998) |
|---|---|
| L-dopa peroxidase | <enzyme> Found in human erythrocytes associated with catalase Registry number: EC 1.11.- (26 Jun 1999) |
| L-dopa |
the levorotatory form of dopa (trade names Bendopa and Brocadopa and Larodopa); as a drug it is used to treat Parkinson's disease
Ãâó: wordnet.princeton.edu/perl/webwn
|
|---|---|
| L-dopa |
A chemical related to dopamine that is used in the treatment of Parkinson's disease.
Ãâó: www.emc.maricopa.edu/faculty/farabee/BIOBK/BioBook...
|
| L-dopa |
This is a drug used to alleviate some of the symptoms of Parkinson's disease (see below), particularly trembling, rigidity, and slow movements; the drug is also called levodopa. Parkinson's disease results when the concentration of dopamine in the brain is depleted. L-dopa enters the brain through the bloodstream more easily than dopamine itself, and is there converted into dopamine. ...
Ãâó: www.macalester.edu/~psych/whathap/UBNRP/nightmares...
|
| L-dopa |
also called dopaminergic agents; a dopamine-enhancing class of drugs most often used to treat Parkinson
Ãâó: www.sleepcompliance.com/html/glossary.htm
|
| L-DOPA | the levorotatory form of dopa (trade names Bendopa and Brocadopa and Larodopa) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|